Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021.

This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.

• Publication year

  2024

• Venue

  JAMA cardiology

• Publication date

  2024-04-24

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.1001/jamacardio.2024.0615PMID 38656398PMCID PMC11044007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Demographic and Regional Trends of Heart Failure-Related Mortality in Young Adults in the US, 1999-2019.

  2022cited by this paper
• Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics

  2020cited by this paper
• Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000–2015

  2017cited by this paper

• Housing Cost Burden and Outcomes Among Medicaid Beneficiaries With Heart Failure

  2026cites this paper
• Trends in Cardiovascular Mortality Among Disaggregated Asian American Subgroups: 2018-2022

  2026cites this paper
• Gender- and sex-dependent variations in heart failure and cardiomyopathies: a review of the literature.

  2026cites this paper
• Heart Failure Outcomes Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.

  2026cites this paper
• Development and explanation of electrocardiogram-based deep learning for predicting short-term mortality in heart failure patients

  2026cites this paper
• Large-Scale Proteomic Profiling of Incident Heart Failure and Its Subtypes in Older Adults.

  2026cites this paper
• Cardiovascular Statistics in the United States, 2026: JACC Stats.

  2026cites this paper
• SPIROMICS HF: Rationale, Design, and Reproducibility of Measures.

  2025cites this paper
• Sleep quality and outcomes in preclinical heart failure: a prospective UK Biobank cohort study.

  2025cites this paper
• Molecular Phenogroups in Heart Failure: Large-Scale Proteomics in a Population-Based Cohort

  2025cites this paper
• Prognostic Impact of LVEF Recovery in Young Adults With Acute Heart Failure

  2025cites this paper
• Integrated Systems Biology Identifies Disruptions in Mitochondrial Function and Metabolism as Key Contributors to HFpEF

  2025cites this paper
• Early Cardiac Dysfunction in Adolescents With Low Vigorous Physical Activity

  2025cites this paper
• Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC

  2025cites this paper
• Heart failure‐attributed mortality in Europe, 2012–2021

  2025cites this paper
• Therapeutic Implications of ErbB Pathway Modification in Heart Failure with Reduced Ejection Fraction

  2025cites this paper
• A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk.

  2025cites this paper
• Trends in Mortality Rates for Cardiovascular Disease Subtypes Among Adults, 2010-2023.

  2025cites this paper
• HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America.

  2025cites this paper
• Microglial metabolic reprogramming drives cognitive decline in heart failure with preserved ejection fraction

  2025cites this paper
• Heart Failure Devices: Treatment Options, Underutilization, and a Proposed Trigger System for Patient Referral and Evaluation.

  2025cites this paper
• Anemia is Associated with Incident Heart Failure in Younger Males

  2025cites this paper
• Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review.

  2025cites this paper
• Anemia: Marker, Mechanism, or Modifiable Target for Heart Failure?

  2025cites this paper
• Characteristics and outcomes in outpatients with heart failure in Russia: results of a large-scale prospective observational multicenter registry study PRIORITY-HF

  2025cites this paper
• Cost-Effectiveness of Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention in Severe Ischemic Cardiomyopathy

  2025cites this paper
• Timing of inotropic support is associated with mortality in patients with acute decompensated heart failure-associated cardiogenic shock

  2025cites this paper
• The Society of Thoracic Surgeons Intermacs 2025 Annual Report: Focus on Outcomes in Older Adults.

  2025cites this paper
• Advances in the management of acute decompensated heart failure

  2025cites this paper
• Demographic and regional disparities in acute kidney injury-related heart failure mortality among American adults from 1999 to 2023: A retrospective cohort study using the CDC WONDER database

  2025influential citation
• Venting the Venous Circulation: A Novel Approach to Decongestion in Heart Failure.

  2025cites this paper
• Novel Use of Autologous Cell Therapy in Ischemic Heart Failure.

  2025cites this paper
• Prediction of mortality in heart failure by machine learning. Comparison with statistical modeling.

  2025cites this paper
• Therapeutic Appraisal in Protracted Heart Failure.

  2025cites this paper
• Incident prescriptions for common cardiovascular medications: comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems

  2025cites this paper
• Obesity Management for Patients with Coronary Artery Disease and Heart Failure.

  2025cites this paper
• What's new in heart failure? February 2025

  2025cites this paper
• ECGSmart: Revolutionizing Cardiovascular Disease Diagnosis and Management through AI-Powered Real-Time Analysis and Personalized Health Guidance

  2025cites this paper
• Disparities in heart failure deaths among people with diabetes in the United States: 1999–2020

  2025cites this paper
• Retrospective Evaluation and Analysis of Pharmacoequity with Guideline-directed Medical Therapy in Heart Failure with Reduced Ejection Fraction (REAP-HF)

  2025influential citation
• To Reverse Rising Heart Failure Mortality, We Must Address Evidence Gaps.

  2025cites this paper
• Heart Rate and Prognosis of Heart Failure with Reduced Ejection Fraction in Women and Men in Sinus Rhythm

  2025cites this paper
• Drug Discovery and Development for Heart Failure Using Multi-Omics Approaches

  2025cites this paper
• JAMA Cardiology-The Year in Review 2024.

  2025cites this paper
• Understanding Cardiovascular Mortality: A Deep Dive Into the Differences Between GBD and CDC WONDER.

  2025cites this paper
• Comparing Cardiovascular Mortality Estimates From Global Burden of Disease and From the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research

  2025cites this paper
• Outcomes of early post-discharge cardio-geriatric care in frail patients after acute heart failure: a before-and-after study

  2025cites this paper
• Myocardial flow reserve and resting contractility modulate the impact of contractile reserve in patients undergoing rubidum-82 positron emission tomography

  2025cites this paper
• Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association

  2025cites this paper
• Rising Mortality Related to Diabetes Mellitus and Hypertension: Trends and Disparities in the United States (1999−2023)

  2025cites this paper
• Rethinking the Impact of Single Continuing Educational Activities: Navigating Complexity Through Insights from Real-World Evaluation and Contemporary Literature

  2025cites this paper
• Building a Heart Failure Workforce for the 21st Century.

  2025cites this paper
• Cardiologist follow-up and improved outcomes of heart failure: a French nationwide cohort

  2025cites this paper
• Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos

  2025cites this paper
• Patterns of comorbidities differentially impact on in-hospital outcomes in heart failure patients

  2025cites this paper
• Screening for Undiagnosed Heart Failure: A Viewpoint.

  2025cites this paper
• Are Early-Onset Cancers an Example of Accelerated Biological Aging?

  2025cites this paper
• Failure to Launch: Insights From Randomized Trials on Implementation Strategies for Guideline-Directed Therapies for Heart Failure.

  2025cites this paper
• HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America.

  2024cites this paper
• Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995–2020: a retrospective secondary data analysis

  2024cites this paper
• Safety and Feasibility of an Implanted Inferior Vena Cava Sensor for Accurate Volume Assessment: FUTURE-HF2 Trial.

  2024cites this paper
• National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2021.

  2024cites this paper
• Ten hour donor heart ischemic time with 10ºC static storage

  2024cites this paper
• Harnessing the lymphatic system

  2024cites this paper
• Modulating Sympathetic Nervous System With the Use of SGLT2 Inhibitors: Where There Is Smoke, There Is Fire?

  2024cites this paper
• The Society of Thoracic Surgeons Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients.

  2024cites this paper
• Free fatty acids: independent predictors of long-term adverse cardiovascular outcomes in heart failure patients

  2024cites this paper
• Trends in heart failure mortality in Sweden between 1997 and 2022

  2024cites this paper
• Integrated systems biology identifies disruptions in mitochondrial function and metabolism as key contributors to heart failure with preserved ejection fraction (HFpEF)

  2024cites this paper
• Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records.

  2024cites this paper
• Reply to the letter regarding the article ‘Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure?’

  2024cites this paper
• Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure

  2024cites this paper
• Global, regional, and national burdens of heart failure in adolescents and young adults aged 10–24 years from 1990 to 2021: an analysis of data from the Global Burden of Disease Study 2021

  2024cites this paper
• Identification of Disease-Relevant, Sex-Based Proteomic Differences in iPSC-Derived Vascular Smooth Muscle Cells

  2024cites this paper
• Digital Health: From Remote Monitoring to Remote Care.

  2024cites this paper
• Trends in Mortality After Incident Hospitalization for Heart Failure Among Medicare Beneficiaries

  2024cites this paper
• Leveraging digital health technologies in heart failure self-care interventions to improve health equity.

  2024cites this paper
• Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population

  2024cites this paper
• Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry

  2024cites this paper
• Digital health as a tool for patient activation and improving quality of care for heart failure

  2024cites this paper
• Myocardial Recovery in the Systemic Context: A Philosophic Shift for the Heart Failure Subspecialty to Optimize Patient Care

  2024cites this paper
• Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure

  2024cites this paper